Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare IT M&A.
Sagility Acquires CareSeed to Accelerate AI-Led Quality Operations and Medicare Advantage Performance Transformation
Acquisition Expands Sagility’s Healthcare Quality, HEDIS, and Care Gap Orchestration Capabilities for Health Plans
Sagility, a leading tech-enabled healthcare operations and transformation company, today announced its acquisition of CareSeed, a U.S.-based healthcare analytics company specializing in NCQA-certified HEDIS quality reporting, medical record review, chart abstraction, and regulatory analytics for health plans.
Founded in 2012 and headquartered in Kansas City, Missouri, CareSeed serves 30 small and mid-sized U.S. payers, with a strong footprint in Medicare Advantage. The company’s cloud-native platforms, Forecast and Harvest, help health plans improve HEDIS performance, streamline chart abstraction and medical record review workflows, strengthen audit readiness, and manage increasingly complex regulatory requirements.
The acquisition represents a strategic expansion of Sagility’s healthcare quality and Stars capabilities and advances the company’s broader vision of moving health plans beyond retrospective HEDIS reporting toward integrated, member-level quality orchestration.
By combining CareSeed’s technology with Sagility’s healthcare operations, clinical services, and AI-led transformation capabilities, Sagility will deliver an end-to-end quality operations continuum.
The combined offering will support health plans across the full quality lifecycle — from HEDIS abstraction and reporting to prospective gap closure, provider engagement, care coordination, and continuous performance monitoring.
“CareSeed has built strong capabilities in quality measurement, HEDIS reporting, and healthcare analytics that have helped health plans navigate an increasingly complex regulatory environment,” said Ramesh Gopalan, Managing Director and Group Chief Executive Officer at Sagility…
Full release here, originally announced June 11th, 2026.
Model N Acquires Kalderos to Expand its 340B Capabilities and Gross-to-Net Revenue Management
Deal Adds Claims-Level Visibility to Help Manufacturers Identify Duplicate Discounts Earlier and Reduce Revenue Leakage
Model N, a leading end-to-end commercialization, revenue optimization, and compliance platform for life sciences companies, announced it has acquired Kalderos, a technology company that provides a gross-to-net (GTN) intelligence platform with rich capabilities for driving visibility into 340B drug discount programs.
The acquisition will expand Model N’s capabilities as a leading revenue management platform for life sciences manufacturers and extend its 340B offerings to better serve customers. 340B, a federal program that requires drug manufacturers to sell outpatient drugs at discounted prices to eligible safety-net hospitals and clinics, is a core and growing component of the overall GTN value chain.
Manufacturers are managing 340B amid Medicare drug price negotiations, potential future pricing models such as most-favored-nation (MFN), and growing scrutiny of 340B claims-level data requirements. These pressures are increasing the need to identify discount discrepancies and optimize revenue. Model N’s 2026 State of Revenue Report found that only 1% of life sciences revenue leaders have real-time visibility into 340B discounts, Medicaid and Medicare rebates, and utilization rebates.
Kalderos’ Truzo solution directly addresses these challenges through an end-to-end drug discount management platform that provides real-time data visibility across multiple drug discount programs, enabling effective compliance monitoring, claim validation, and dispute resolution between manufacturers and covered healthcare providers. The added 340B data also strengthens Model N’s advanced analytics strategy, giving manufacturers more complete information across the revenue lifecycle.
“Model N delivers the commercial platform life sciences leaders rely on to expand market access, optimize revenue, and maintain compliance,” said Bret Connor, CEO at Model N…
Full release here, originally announced June 17th, 2026.
No comments:
Post a Comment